Alpha 2.0
Login Register
» Authors » Federico Gimeno de Carlos

Federico Gimeno de Carlos

Explore the profile of Federico Gimeno de Carlos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 90
Followers 0
Related Specialty
Cardiology & Vascular Diseases
Top 10 Co-Authors
Jose M de la Torre Hernandez
Tamara Garcia Camarero
Javier Zueco Gil
Angel Sanchez Recalde
Joan A Gomez Hospital
Jose A Fernandez Diaz
Jose R Rumoroso
Victoria Martin Yuste
Armando Perez de Prado
Felipe Hernandez Hernandez
Published In
Rev Esp Cardiol (Engl Ed)
JACC Cardiovasc Interv
BMC Cardiovasc Disord
Heart
Affiliations
Soon will be listed here.
Recent Articles
1.
Antithrombotic treatment during coronary angioplasty after failed thrombolysis: strategies and prognostic implications. Results of the RESPIRE registry
de la Torre Hernandez J, Sadaba Sagredo M, Telleria Arrieta M, Gimeno de Carlos F, Sanchez Lacuesta E, Bullones Ramirez J, et al.
BMC Cardiovasc Disord . 2017 Aug; 17(1):212. PMID: 28764639
Background: Thrombolysis is still used when primary angioplasty is delayed for a long time, but 25%-30% of patients require rescue angioplasty (RA). There are no established recommendations for antithrombotic management...
2.
Primary Angioplasty in Patients Older Than 75 Years. Profile of Patients and Procedures, Outcomes, and Predictors of Prognosis in the ESTROFA IM+75 Registry
de la Torre Hernandez J, Brugaletta S, Gomez Hospital J, Baz J, de Prado A, Lopez Palop R, et al.
Rev Esp Cardiol (Engl Ed) . 2016 Nov; 70(2):81-87. PMID: 27840148
Introduction And Objectives: The proportion of elderly patients undergoing primary angioplasty is growing. The present study describes the clinical profile, procedural characteristics, outcomes, and predictors of outcome. Methods: A 31-center...
3.
Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure
Lopez Minguez J, Asensio J, Elduayen Gragera J, Costa M, Cruz Gonzalez I, Gimeno de Carlos F, et al.
Heart . 2015 Jan; 101(11):877-83. PMID: 25573984
Aims: The aim of this study was to observe the percentage of thromboembolic and haemorrhagic events over a 2-year follow-up in patients with non-valvular atrial fibrillation (NVAF) undergoing closure of...
4.
Initial experience of percutaneous treatment of mitral regurgitation with MitraClip® therapy in Spain
Carrasco-Chinchilla F, Arzamendi D, Romero M, Gimeno de Carlos F, Alonso-Briales J, Li C, et al.
Rev Esp Cardiol (Engl Ed) . 2014 Nov; 67(12):1007-12. PMID: 25432711
Introduction And Objectives: Symptomatic mitral regurgitation has an unfavorable prognosis unless treated by surgery. However, the European registry of valvular heart disease reports that 49% of patients with this condition...
5.
Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
de la Torre Hernandez J, Masotti Centol M, Lerena Saenz P, Sanchez Recalde A, Gimeno de Carlos F, Esteban P, et al.
Rev Esp Cardiol (Engl Ed) . 2014 Apr; 67(5):353-8. PMID: 24774727
Introduction And Objectives: Percutaneous transluminal septal ablation is an alternative treatment in patients with hypertrophic obstructive cardiomyopathy. However, due to the relatively new introduction of this technique, there is no...
6.
Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries
de la Torre Hernandez J, Baz Alonso J, Gomez Hospital J, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, et al.
JACC Cardiovasc Interv . 2014 Mar; 7(3):244-54. PMID: 24650399
Objectives: This study sought to investigate the clinical impact of the use of intravascular ultrasound (IVUS) during revascularization of patients with left main coronary artery (LM) disease with drug-eluting stents...